Navigation Links
Global Drug Discovery Technologies Market to Exceed $57 Billion by 2012, According to a New Report by Global Industry Analysts

Driven by the emergence of innovative technologies such as microfluidics, genomics, high throughput screening and proteomics, world market for drug discovery technologies is projected to reach $57.7 billion by 2012. Despite the heavy costs involved in discovery of new drugs, investments in pharmaceutical research and development are reaching new highs encouraged by evolving medical standards, favorable demographic trends and shifting preferences of the medical community towards technologically advanced products.

San Jose, CA (PRWEB) November 4, 2008 -- Drug discovery has become an integral and ongoing element of every pharmaceutical company's business strategy. There are a number of new technologies that are increasingly being used to enhance pharmaceutical R&D. These technologies include bioanalytical instruments, genomics, pharmacogenomics, combinatorial chemistry, biochip, proteomics, bioinformatics and high throughput screening (HTS). Use of emerging technologies in drug discovery such as lab on a chip (LOC), nanotechnology and RNA interference (RNAi) is increasing at a rapid pace given their ability to expedite, and improve the efficiency of drug discovery processes and reducing time-to-market.

As stated by the recent report published by Global Industry Analysts, Inc., drug discovery technologies market is dominated by the United States and Europe, which together account for over 78% of the world market estimated in the year 2008. Worldwide Bioanalytical instruments market, the largest segment of the drug discovery technologies market, is projected to rise by US$7827.9 million over the period 2008 to 2012. Driven by aging population, rise in disease incidence, and favorable governmental initiatives, market for Pharmacogenomics in Europe is projected to reach US$2.6 billion by 2015. Pharmacogenomics testing helps optimize drug therapy by enabling the study of gene interactions with drugs. This thereby lowers the number of clinical trials and the cost and time pressures involved therein.

Major pharmaceutical companies have been aggressively conducting internal research and development programs to generate new marketable products, materials and technologies. Although the number of new products emerging from R&D each year is rising significantly, percentage of successful product commercialization and launches averages to just 10-15% of drugs under research. Given the hefty funds that need to be injected into clinical trials of new drugs, pharmaceutical outsourcing is gaining preeminence in both the drug discovery and drug development phases. Pharmaceutical companies are also forming collaborations with drug discovery facilitators such as Contract Research Organizations (CRO), and university research centers.

Key players in the global and regional Drug Discovery Technologies market include Abbott Laboratories, Affymetrix, Agilent Technologies, Albany Molecular Research, Amersham Biosciences, Applera Corporation, ArQule, AstraZeneca, BD Biosciences, Bio-Rad Laboratories, BioSciences Group, Caliper Life Sciences, Capital GenomiX, Caprion Proteomics, Charles River Laboratories International, ChemBridge Corporation, deCODE Genetics, Evotec AG, Galapagos NV, Incyte Corporation, Infinity Pharmaceuticals Inc, Invitrogen Corporation, Medarex, Merck & Co., Millennium Pharmaceuticals, National Center for Drug Screening, PerkinElmer, Pharmacopeia Inc, Proteome Systems, Quantum Pharmaceuticals, Shimadzu, Sigma-Aldrich, Tecan Group, Thallion Pharmaceuticals Inc, and Tripos, among others.

The report, titled "Drug Discovery Technologies: A Global Strategic Business Report" published by Global Industry Analysts, Inc., provides a comprehensive review of market trends, industry overview, product overview, product introductions/innovations, and recent industry activity. The report analyzes market data and analytics in value sales for regions such as the United States, Canada, Japan, Europe, and Rest of World. The study also analyzes the Drug Discovery Technologies market by the following technologies - bioanalytical instruments, high throughput screening (HTS), biochip market, proteomics, genomics market, bioinformatics, pharmacogenomics market, and other drug discovery technologies.

For more details about this research report, please visit

About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a reputed publisher of off-the-shelf market research. Founded in 1987, the company is globally recognized as one of the world's largest market research publishers. The company employs over 700 people worldwide and publishes more than 880 full-scale research reports each year. Additionally, the company also offers a range of over 60,000 smaller research products including company reports, market trend reports, and industry reports encompassing all major industries worldwide.

Global Industry Analysts, Inc.
Telephone 408-528-9966
Fax 408-528-9977
Email press @
Web Site


Read the full story at

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Related biology technology :

1. MannKind to Present at the Rodman & Renshaw Annual Global Investment Conference
2. Catalyst Pharmaceutical Partners to Present at the Rodman & Renshaw 10th Annual Global Investment Conference
3. Microplate Instrumentation & Supplies Market to Exceed $5.0 Billion by 2015, According to New Report by Global Industry Analysts, Inc
4. Medizone International, Inc. Announces Establishment of Canadian Foundation for Global Health
5. DNA 11, Creators of DNA Art Goes Global
6. Genetic Testing Market to Exceed $6.6 Billion by 2015, According to New Report by Global Industry Analysts, Inc.
7. Tianyin Pharmaceutical Co., Inc. to Present at Rodman & Renshaw Annual Global Investment Conference in New York City on November 11, 2008 at 12:00 p.m. EST
8. Titrators Market to Reach $315 Million by 2015, According to New Report by Global Industry Analysts, Inc.
9. China Yingxia to Present at Rodman & Renshaw Annual Global Investment Conference
10. Consumers Looking to Sustainable Food Production to Feed Global Population
11. Laboratory Pumping Systems to Reach $3.1 Billion by 2012, According to New Report by Global Industry Analysts, Inc.
Post Your Comments:
Related Image:
Global Drug Discovery Technologies Market to Exceed $57 Billion by 2012, According to a New Report by Global Industry Analysts
(Date:11/24/2015)... 2015 --> ... "Oligonucleotide Synthesis Market by Product & Services (Primer, Probe, ... DNA, RNAi), End-User (Research, Pharmaceutical & Biotech, Diagnostic Labs) ... market is expected to reach USD 1,918.6 Million by ... CAGR of 10.1% during the forecast period. ...
(Date:11/24/2015)... LEXINGTON, Massachusetts , November 24, 2015 ... Officer, will participate in the Piper Jaffray 27 th Annual ... on Tuesday, December 1, 2015, at 8:30 a.m. EST (1:30 p.m. ... Poulton , Chief Financial Officer, will participate in the Piper Jaffray ... City , NY on Tuesday, December 1, 2015, at 8:30 ...
(Date:11/24/2015)... Nov. 24, 2015 /PRNewswire/ - Aeterna Zentaris Inc. ... that the remaining 11,000 post-share consolidation (or 1,100,000 ... (the "Series B Warrants") subject to the previously ... November 23, 2015, which will result in the ... effect to the issuance of such shares, there ...
(Date:11/24/2015)... , ... November 24, 2015 , ... InSphero AG, the ... cell culture models, has promoted Melanie Aregger to serve as Chief Operating Officer. ... served on the management team and was promoted to Head of InSphero ...
Breaking Biology Technology:
(Date:11/20/2015)... OXFORD, Connecticut , November 20, 2015 ... biometric authentication company focused on the growing mobile commerce ... its CEO, Gino Pereira , was recently interviewed ... The interview will air on this weekend on ... Bloomberg Latin America . --> NXTD ) ...
(Date:11/18/2015)... 2015  As new scientific discoveries deepen our understanding ... healthcare providers face challenges in better using that knowledge ... addition, as more children continue to survive pediatric cancer, ... old age. John M. Maris, M.D ., ... Philadelphia (CHOP) . --> John M. ...
(Date:11/17/2015)... -- Paris , qui s,est ... Paris , qui s,est tenu du 17 ... de l,innovation biométrique, a inventé le premier scanner couplé, ... la même surface de balayage. Jusqu,ici, deux scanners étaient ... empreintes digitales. Désormais, un seul scanner est en mesure ...
Breaking Biology News(10 mins):